Trials / Completed
CompletedNCT01386684
Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study
Canadian Real-Life Evaluation of the Effectiveness of Lupron in the Management of Prostate Cancer (CRONOS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 552 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Canadian Real Life Evaluation of the Effectiveness of Lupron in the Management of Prostate Cancer.
Detailed description
This is a Canadian Post Marketing Observational Study utilizing a prospective cohort design. Patients with Prostate Cancer who are prescribed Lupron will be entered into the study cohort and will be followed for a maximum of 36 months with recommended assessments at 3, 6, 12, 18, 24, 30 and 36 months after baseline. Treatment of the patients and follow up will be according to the physician's judgment, regional regulations and the product monograph.
Conditions
Timeline
- Start date
- 2011-06-28
- Primary completion
- 2016-09-08
- Completion
- 2016-09-08
- First posted
- 2011-07-01
- Last updated
- 2018-12-13
- Results posted
- 2018-04-02
Source: ClinicalTrials.gov record NCT01386684. Inclusion in this directory is not an endorsement.